Press release: Facio anounces completion of real-world data study in FSHD

Click below to read the press release of our sponsor, Facio Therapies, announcing the completion of an exploratory study conducted by CHDR to evaluate the utility of real-world data for monitoring the progression of FSHD and the impact of FSHD on daily life. Not only does this study represent the very first effort in the FSHD field to ultimately discover clinical outcome measures based on real-world patient data obtained with the use of digital technologies, it also further validates our CHDR MORE® wearables/home monitoring platform.

Full press release